Work

Engineered extracellular vesicles for peritoneal dialysis-associated peritoneal fibrosis: therapeutic engineering and translational strategies

Year: 2026
Type: article
Abstract: Peritoneal fibrosis (PF) is a major complication that limits the long-term use of peritoneal dialysis. Its core pathological mechanisms include chronic inflammation, mesothelial-mesenchymal transition, and imbalances in extracellular matrix metabolism. Extracellular vesicles (EVs), as key mediators of intercellular communication, have demonstrated unique value in the early diagnosis and therapeutic intervention of PF in recent years. EVs in peritoneal dialysis effluent carry molecular cargo, including aquaporin-1 (AQP1), miR-432-5p, glycoprotein 96 (gp96), and integrin-linked kinase (ILK), that can dynamically reflect the severity of ultrafiltration failure and fibrosis, thereby establishing a framework for a noninvasive liquid biopsy. Functionally, EVs play dual roles in both promoting and inhibiting fibrosis: ILK-rich EVs derived from mesothelial cells activate fibroblasts via the p38 MAPK pathway, whereas EVs derived from mesenchymal stem cells (MSCs) inhibit the mesothelial-to-mesenchymal transition (MMT). Engineered EVs are emerging as a hot topic in translational research. However, EV heterogeneity, insufficient in vivo tracing, and the model-clinical gap remain key bottlenecks. The integration of single-EV analysis, peritoneal organoids, and AI-driven multi-omics approaches is expected to drive a paradigm shift from “populations of vesicles” to “spatiotemporal functions of individual vesicles.”
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234381394
FWCI:
Cites: 118
Cited by:
Related to: 10